|
A promising new treatment for refractory aplastic anemia
|
Jul 2012
|
N Engl J Med
|
aplastic anemia
|
|
Eltrombopag and improved hematopoiesis in refractory aplastic anemia
|
Jul 2012
|
N Engl J Med
|
aplastic anemia
|
|
Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated?
|
Jul 2012
|
Ann Hematol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations.
|
Jul 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Successful Use of Eculizumab in a Pediatric Patient Treated for Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2012
|
J Pediatr Hematol Oncol
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Commentary on "clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Why are myelodysplastic syndromes unrecognized and underdiagnosed?: a primary care perspective
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: therapy and outlook
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Commentary on "myelodysplastic syndromes: therapy and outlook"
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: challenges to improving patient and caregiver satisfaction
|
Jul 2012
|
Am J Med
|
myelodysplastic syndromes (MDS)
|
